Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Healthy Returns

Recent news which mentions Healthy Returns

< Previous 1 2 Next >
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Tags Amgen Inc LILLY DRN Social issues
From CNBC.com News
Healthy Returns: What to know about the FDA’s plan to speed up some drug reviews
Tags Health & Science Social issues Cigna Corp
From CNBC.com News
Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Tags Health & Science Bristol/Myers Squibb Co Amazon/com Inc
From CNBC.com News
Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
Tags Hinge Health Inc Pfizer Inc Health care industry
From CNBC.com News
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
Tags Moderna Inc Health & Science Social issues
From CNBC.com News
Healthy Returns: Trump provides a glimpse of the third round of Medicare drug price negotiations
Tags Health & Science Social issues Merck & Co Inc
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags LILLY DRN Social issues Health & Science
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
Tags Merck & Co Inc Social issues Health care industry
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags Elevance Health Inc Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
Tags Social issues Health & Science LILLY DRN
From CNBC.com News
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’
Tags Social issues Health & Science Healthy Returns
From CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Tags Health & Science Merck & Co Inc LILLY DRN
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags Social issues Health & Science Science
From CNBC.com News
Healthy Returns: What to know about the U.S. measles outbreak
Tags Healthy Returns Alphabet Inc Health & Science
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Healthy Returns Dexcom Inc Health care industry
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Amazon/com Inc Biotech and Pharmaceuticals Structure Therapeutics Inc
From CNBC.com News
Healthy Returns: HHS Secretary RFK Jr. is making early moves that may affect vaccine access
Tags Social issues Health & Science Oracle Corp
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Healthy Returns CVS Health Corp Health care industry
From CNBC.com News
Healthy Returns: What to know about Trump's NIH funding cuts
Tags Biotech and Pharmaceuticals Health care industry Social issues
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Science LILLY DRN Social issues
From CNBC.com News
Healthy Returns: Trump made sweeping changes to health care in his first week
Tags Health care industry Biotech and Pharmaceuticals UnitedHealth Group Inc
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Health & Science Social issues Health care industry
From CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Tags Madrigal Pharmaceuticals Inc Dexcom Inc Accolade Inc
From CNBC.com News
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Tags Health & Science Bristol/Myers Squibb Co LILLY DRN
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Science Social issues Health & Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Health & Science Social issues
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Health & Science LILLY DRN Bristol/Myers Squibb Co
From CNBC.com News
Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say
Tags Healthy Returns Health & Science Social issues
From CNBC.com News
Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
Tags Biotech and Pharmaceuticals Novartis AG Health care industry
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.